Home › Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia clinical trials recruiting in the U.S.
8 studies for Congenital Adrenal Hyperplasia are recruiting participants at sites across the United States.
Cities with the most studies
- Ann Arbor, MI4 studies
- Minneapolis, MN3 studies
- Chicago, IL3 studies
- Philadelphia, PA3 studies
- Rochester, MN3 studies
By state
- California3 studies
- Illinois3 studies
- Maryland3 studies
- Michigan4 studies
- Minnesota5 studies
- Pennsylvania3 studies
- Texas3 studies
Recently updated studies
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
RecruitingPhase 2/3
Ages 1 to 17 · All sexes · Updated Sep 30, 2026 · NCT07159841A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 30, 2026 · NCT07144163Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07138274Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
RecruitingPhase 2
3 Months – 47 Months · All sexes · Updated Sep 16, 2026 · NCT07536269Natural History Study of Patients With Excess Androgen
RecruitingObservational study
1 Day – 99 Years · All sexes · Updated Sep 8, 2026 · NCT00250159A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Mar 9, 2026 · NCT05669950Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT07247058Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 11, 2026 · NCT07104812From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.